Access cutting-edge lung cancer treatment through this clinical trial at a research site in Modesto. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Modesto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividin
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this lung cancer clinical trial in Modesto, CA
If you're searching for lung cancer treatment options in Modesto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Modesto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.